VAQTA™: Clinical Trials

5 trials of VAQTA™, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting. 4 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 2, Completed 2
Phase 41Completed 1

Follow VAQTA™: new trials by email Literature Review of VAQTA™ trials Research Report on VAQTA™

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
PCV21 vaccine, Prevnar 20 vaccine, M-M-R II vaccine - Pneumococcal Immunization
Phase 3Active not recruitingSanofi5802025-02-272026-02-13
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
PCV21 vaccine, Prevnar 20 vaccine, M-M-R II vaccine - Pneumococcal Immunization
Phase 3Active not recruitingSanofi23602025-02-182026-04-13
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)
V114, Prevnar 13™, RotaTeq™ - Pneumococcal Infections, Pneumococcal Vaccines
Phase 3CompletedMerck Sharp & Dohme LLC17202019-06-192023-07-28
A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)
Hepatitis A Vaccine, Purified Inactivated (VAQTA™) - Hepatitis A Virus Infection
Phase 3CompletedMerck Sharp & Dohme LLC802008-03-012017-04-13
Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
TWINRIX™, Engerix™-B, HAVRIX™ - Hepatitis B, Hepatitis A
Phase 4CompletedGlaxoSmithKline5962003-11-242019-11-15

Conditions studied

Hepatitis A (1)  ·  Hepatitis B (1)  ·  Pneumococcal Infections (1)

Sponsors

Merck Sharp & Dohme LLC (2)  ·  Sanofi (2)  ·  GlaxoSmithKline (1)

Countries

United States (3)  ·  Mexico (2)  ·  Puerto Rico (2)  ·  Thailand (2)  ·  Turkey (Türkiye) (2)  ·  Belgium (1)  ·  Chile (1)  ·  Czechia (1)  ·  Germany (1)  ·  Honduras (1)  ·  Philippines (1)

Results publications

PMID 36621410, PMID 37846456

NIH funding

2018 (1)